Green Thumb Industries (GTBIF) versus Its Rivals Head to Head Review

Green Thumb Industries (OTCMKTS:GTBIF) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its competitors? We will compare Green Thumb Industries to similar businesses based on the strength of its earnings, risk, analyst recommendations, institutional ownership, valuation, profitability and dividends.

Valuation and Earnings

This table compares Green Thumb Industries and its competitors top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Green Thumb Industries	$1.18 billion	$114.15 million	16.14
Green Thumb Industries Competitors	$1.89 billion	$136.81 million	11.10

Green Thumb Industries’ competitors have higher revenue and earnings than Green Thumb Industries. Green Thumb Industries is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Green Thumb Industries and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Green Thumb Industries	7.94%	5.24%	3.50%
Green Thumb Industries Competitors	-304.51%	-178.77%	-22.17%

Risk and Volatility

Green Thumb Industries has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, Green Thumb Industries’ competitors have a beta of 2.57, suggesting that their average stock price is 157% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Green Thumb Industries and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Green Thumb Industries	0	1	1	0	2.50
Green Thumb Industries Competitors	4280	10550	18328	829	2.46

Green Thumb Industries presently has a consensus target price of $18.00, suggesting a potential upside of 165.49%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.22%. Given Green Thumb Industries’ stronger consensus rating and higher probable upside, equities analysts clearly believe Green Thumb Industries is more favorable than its competitors.

Institutional and Insider Ownership

0.1% of Green Thumb Industries shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 9.4% of Green Thumb Industries shares are owned by insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Green Thumb Industries competitors beat Green Thumb Industries on 7 of the 13 factors compared.

Green Thumb Industries Company Profile

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. It distributes its products primarily to third-party retail customers and sells finished products directly to consumers in its own retail stores, as well as direct-to consumer delivery channel. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.